Cited by 5,228Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsLiver physiology and pathology

The DOI matches its Crossref record; 90 of the 92 references it cites were found in a registry or an index, and 2 are not checked yet.

Nonalcoholic Fatty Liver Disease

Angulo, Paul·2002·New England Journal of Medicine

DOI 10.1056/nejmra011775

Open this paper in CoChat — free account

Abstract

Alcohol abuse is the most common cause of fatty liver disease, but it is now apparent that fat deposition in the liver, and its consequences, may occur without alcohol abuse. The principal risk factors are obesity, non-insulin-dependent diabetes mellitus, and hyperlipidemia. The disorder has a wide clinical spectrum, ranging from asymptomatic steatosis to steatohepatitis, fibrosis, and cirrhosis. This article provides a broad overview of this increasingly recognized liver disease.

Integrity signals

Registry

Crossref · 10.1056/nejmra011775

Cites

90 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078

Show all 90 references

Research works printed but not linked: 9

Schaffner F, 1986, Prog Liver Dis, 8, 283
Itoh S, 1987, Am J Gastroenterol, 82, 650
Silverman JF, 1990, Am J Gastroenterol, 85, 1349
Creutzfeldt W, 1970, Prog Liver Dis, 3, 371
Silverman JF, 1989, Pathol Annu, 24, 275
Debaere C, 1998, J Belge Radiol, 81, 174
Zatloukal K, 1991, Lab Invest, 64, 200
Curzio M, 1985, Int J Tissue React, 7, 137
Watson AM, 1999, Drug Metab Dispos, 27, 695

Sorted by citations

Items 501–600 of 1,031

Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
Xu, C., Wan, X., Xu, L., Weng, H., Yan, M., Miao, M., Sun, Y., Xu, G.-Y., Dooley, S., Li, Y., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.019 · Cited by 186
Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy
Zhang, Q., & Lu, L. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00037 · Cited by 186
Abdominal Obesity and Fatty Liver
Jakobsen, M. U., Berentzen, T. L., Sørensen, T. I. A., & Overvad, K. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm002 · Cited by 185
Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device
Gori, M., Simonelli, M. C., Giannitelli, S. M., Businaro, L., Trombetta, M., & Rainer, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159729 · Cited by 185
Nonalcoholic steatohepatitis: what we know in the new millennium
Harrison, S. A., Kadakia, S. C., Lang, K. A., & Schenker, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07069.x · Cited by 185
Cyp2e1 Activity Before and After Weight Loss in Morbidly Obese Subjects With Nonalcoholic Fatty Liver Disease
Emery, M. G., Fisher, J. M., Chien, J. Y., Kharasch, E. D., Dellinger, P. E., Kowdley, K. V., & Thummel, K. E. (2003) · Hepatology · doi:10.1053/jhep.2003.50342 · Cited by 185
Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat
Stefan, N., Machicao, F. E., Staiger, H., Machann, J., Schick, F., Tschritter, O., Spieth, C., Weigert, C., Fritsche, A., Stümvoll, M., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1948-3 · Cited by 185
Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers
Park, H., Park, H., Semple, I. A., Jang, I., Ro, S., Kim, M., Cazares, V. A., Stuenkel, E. L., Kim, J., Kim, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5834 · Cited by 184
Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study
Xu, C., Yu, C., Ma, H., Xu, L., Miao, M., & Li, Y. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.104 · Cited by 184
Endoplasmic reticulum stress and liver diseases
Liu, X., & Green, R. M. (2019) · Liver Research · doi:10.1016/j.livres.2019.01.002 · Cited by 184
Targeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet
Cordero, P., Gómez-Uriz, A. M., Campión, J., Milagro, F. I., & Martínez, J. A. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0300-z · Cited by 183
Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
Cussons, A. J., Watts, G. F., Mori, T. A., & Stuckey, B. G. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0870 · Cited by 183
Pilot study of liraglutide effects in non‐alcoholic steatohepatitis and non‐alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN‐J)
Eguchi, Y., Kitajima, Y., Hyogo, H., Takahashi, H., Kojima, M., Ono, M., Araki, N., Tanaka, K., Yamaguchi, M., Matsuda, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12351 · Cited by 182
Accuracy of Liver Fat Quantification at MR Imaging: Comparison of Out-of-Phase Gradient-Echo and Fat-saturated Fast Spin-Echo Techniques—Initial Experience
Qayyum, A., Goh, J. S. K., Kakar, S., Yeh, B. M., Merriman, R. B., & Coakley, F. V. (2005) · Radiology · doi:10.1148/radiol.2372040539 · Cited by 182
The prevalence of nonalcoholic fatty liver disease in the Americas
López‐Velázquez, J. A., Silva-Vidal, K. V., Ponciano‐Rodríguez, G., Chávez-Tapia, N. C., Arrese, M. A., Uribe, M., & Méndez‐Sánchez, N. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30879-8 · Cited by 182
Pathophysiological Role of Osteopontin in Hepatic Inflammation, Toxicity, and Cancer
Ramaiah, S. K., & Rittling, S. R. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm246 · Cited by 182
Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation
Ndumele, C. E., Nasir, K., Conceição, R., Carvalho, J. A. M., Blumenthal, R. S., & Santos, R. D. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228262 · Cited by 182
Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study
Rallidis, L. S., Drakoulis, C., & Parasi, A. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.008 · Cited by 182
Silent non-alcoholic fatty liver disease—a clinical–histological study
Sorrentino, P., Tarantino, G., Conca, P., Perrella, A., Terracciano, L., Vecchione, R., Gargiulo, G., Gennarelli, N., & Lobello, R. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.07.010 · Cited by 182
Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model
Sahai, A., Malladi, P., Melin-Aldana, H., Green, R. M., & Whitington, P. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00002.2004 · Cited by 181
Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.
(2010) · PubMed Central · Cited by 181
Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy
Nishizawa, H., Iguchi, G., Murawaki, A., Fukuoka, H., Hayashi, Y., Kaji, H., Yamamoto, M., Suda, K., Takahashi, M., Seo, Y., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0252 · Cited by 181
Liver governs adipose remodelling via extracellular vesicles in response to lipid overload
Zhao, Y., Zhao, M., Jiang, S., Wu, J., Liu, J., Yuan, X., Shen, D., Zhang, J., Zhou, N., He, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14450-6 · Cited by 181
Specific role for acyl CoA
Villanueva, C. J., Monetti, M., Shih, M., Zhou, P., Watkins, S. M., Bhanot, S., & Farese, R. V. (2009) · Hepatology · doi:10.1002/hep.22980 · Cited by 180
Rutin Attenuates Metabolic Changes, Nonalcoholic Steatohepatitis, and Cardiovascular Remodeling in High-Carbohydrate, High-Fat Diet-Fed Rats
Panchal, S. K., Poudyal, H., Arumugam, T. V., & Brown, L. (2011) · Journal of Nutrition · doi:10.3945/jn.111.137877 · Cited by 180
Hepatoprotective role of Sestrin2 against chronic ER stress
Park, H., Park, H., Ro, S., Jang, I., Semple, I. A., Kim, D. N., Kim, M., Nam, M., Zhang, D., Yin, L., et al. (2014) · Nature Communications · doi:10.1038/ncomms5233 · Cited by 180
Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy
Zhang, F., Zhao, S., Yan, W., Xia, Y., Chen, X., Wang, W., Zhang, J., Gao, C., Peng, C. Y., Yan, F., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.013 · Cited by 180
Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet
Motomura, W., Inoue, M., Ohtake, T., Takahashi, N., Nagamine, M., Tanno, S., Kohgo, Y., & Okumura, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.121 · Cited by 180
Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways
Park, K., Min, A.-K., Koh, E. H., Kim, H. S., Kim, M., Park, H., Kim, Y.-D., Yoon, T.-S., Jang, B. K., Hwang, J. S., et al. (2008) · Hepatology · doi:10.1002/hep.22496 · Cited by 179
ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population
Wang, J., Xu, C., Xun, Y., Lu, Z., Shi, J., Yu, C., & Li, Y. (2015) · Scientific Reports · doi:10.1038/srep16494 · Cited by 179
A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
Temple, J., Cordero, P., Li, J., Nguyen, V., & Oben, J. A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060947 · Cited by 179
The expression of SIRT1 in nonalcoholic fatty liver disease induced by high‐fat diet in rats
Deng, X., Chen, L., & Li, N. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01497.x · Cited by 179
Hepatic adaptations to sucrose and fructose
Bizeau, M. E., & Pagliassotti, M. J. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.004 · Cited by 178
Metabolic Syndrome Is Associated with Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients with NAFLD
Kang, H., Greenson, J. K., Omo, J. T., Chao, C., Peterman, D., Anderson, L., Foess-Wood, L., Sherbondy, M. A. H., & Conjeevaram, H. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00719.x · Cited by 178
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
Willebrords, J., Pereira, I. V. A., Maes, M., Yanguas, S. C., Colle, I. O., Bossche, B. V. D., da Silva, T. C., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A. F., et al. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.05.002 · Cited by 177
Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis
Manco, M., Marcellini, M., Vito, R. D., Comparcola, D., Sartorelli, M. R., & Nobili, V. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803711 · Cited by 177
The Natural History of Non-Alcoholic Fatty Liver Disease
Caldwell, S. H., & Argo, C. K. (2010) · Digestive Diseases · doi:10.1159/000282081 · Cited by 177
The Metabolically Benign and Malignant Fatty Liver
Stefan, N., & Häring, H. (2011) · Diabetes · doi:10.2337/db11-0231 · Cited by 177
Green Tea Extract Protects Leptin-Deficient, Spontaneously Obese Mice from Hepatic Steatosis and Injury1,
Bruno, R. S., Dugan, C. E., Smyth, J. A., DiNatale, D. A., & Koo, S. I. (2008) · Journal of Nutrition · doi:10.1093/jn/138.2.323 · Cited by 177
Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors
Leite, N. C., Villela‐Nogueira, C. A., Pannain, V. L., Caroli‐Bottino, A., Rezende, G. F. M., Cardoso, C. R. L., & Salles, G. F. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02482.x · Cited by 176
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography
Pinzani, M., Vizzutti, F., Arena, U., & Marra, F. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1025 · Cited by 176
Characterization of Distinct Subpopulations of Hepatic Macrophages in HFD/Obese Mice
Morinaga, H., Mayoral, R., Heinrichsdorff, J., Osborn, O., Franck, N., Hah, N., Walenta, E., Bandyopadhyay, G., Pessentheiner, A. R., Chi, T. J., et al. (2015) · Diabetes · doi:10.2337/db14-1238 · Cited by 175
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
Minno, M. N. D. D. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5839 · Cited by 175
Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non‐alcoholic fatty liver disease
Targher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01817.x · Cited by 175
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease
Hotta, K., Yoneda, M., Hyogo, H., Ochi, H., Mizusawa, S., Ueno, T., Chayama, K., Nakajima, A., Nakao, K., & Sekine, A. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-172 · Cited by 175
Obesity-associated mechanisms of hepatocarcinogenesis
Karagozian, R., Derdák, Z., & Baffy, G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.01.011 · Cited by 175
Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease
Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Scala, L., Zenari, L., & Falezza, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02527.x · Cited by 175
Determination of Splenomegaly by CT: Is There a Place for a Single Measurement?
Bezerra, A. S. D. A., D’Ippolito, G., Faintuch, S., Szejnfeld, J., & Ahmed, M. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.5.01841510 · Cited by 175
Nonalcoholic steatohepatitis: a search for factual animal models
Sanches, S. C. L., Ramalho, L. N. Z., Augusto, M. J., da Silva, D. M., & Ramalho, F. S. (2015) · BioMed Research International · doi:10.1155/2015/574832 · Cited by 174
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization
Feldstein, A. E., Werneburg, N. W., Li, Z., Bronk, S. F., & Gores, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00509.2005 · Cited by 174
Myofibroblast – like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario
Parola, M., Marra, F., & Pinzani, M. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.002 · Cited by 174
A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease
İdilman, İ. S., Keskın, O., Çelik, A., Savaş, B., Elhan, A. H., Idılman, R., & Karçaaltıncaba, M. (2015) · Acta Radiologica · doi:10.1177/0284185115580488 · Cited by 174
Metabolic complications of obesity in childhood and adolescence: more than just diabetes
Nathan, B. M., & Moran, A. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f43d19 · Cited by 174
Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissue
Targher, G., Bertolini, L., Scala, L., Zoppini, G., Zenari, L., & Falezza, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01646.x · Cited by 174
High fat diet feeding results in gender specific steatohepatitis and inflammasome activation
Ganz, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8525 · Cited by 173
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
Orešič, M., Hyötyläinen, T., Kotronen, A., Gopalacharyulu, P. V., Nygrén, H., Arola, J. T., Castillo, S., Mattila, I. M., Hakkarainen, A., Borra, R., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2981-2 · Cited by 173
Common Genetic Variants Highlight the Role of Insulin Resistance and Body Fat Distribution in Type 2 Diabetes, Independent of Obesity
Scott, R. A., Fall, T., Pasko, D., Barker, A., Sharp, S. J., Arriola, L., Balkau, B., Barricarte, A., Barroso, I., Boeing, H., et al. (2014) · Diabetes · doi:10.2337/db14-0319 · Cited by 173
Stearoyl‐CoA desaturase as a new drug target for obesity treatment
Dobrzyń, A., & Ntambi, J. M. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00177.x · Cited by 173
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
Campos, G. M., Bambha, K. M., Vittinghoff, E., Rabl, C., Posselt, A. M., Ciovica, R., Tiwari, U., Ferrel, L., Pabst, M. S., Bass, N. M., et al. (2008) · Hepatology · doi:10.1002/hep.22241 · Cited by 173
Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease
Mitsuyoshi, H., Yasui, K., Harano, Y., Endo, M., Tsuji, K., Minami, M., Itoh, Y., Okanoue, T., & Yoshikawa, T. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00464.x · Cited by 172
The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
Honda, Y., Imajo, K., Kato, T., Kessoku, T., Ogawa, Y., Tomeno, W., Kato, S., Mawatari, H., Fujita, K., Yoneda, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146337 · Cited by 172
Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases
Chun, Y. S., Laurent, A., Maru, D. M., & Vauthey, J. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70064-6 · Cited by 171
Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
Bonora, E., & Targher, G. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.79 · Cited by 171
Non-alcoholic fatty liver disease: A sign of systemic disease
Reccia, I., Jayant, K., Akladios, C. Y., Virdis, F., Pai, M., Habib, N., & Spalding, D. R. C. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.011 · Cited by 171
Correlation of Serum TNF-α Levels and Histologic Liver Injury Scores in Pediatric Nonalcoholic Fatty Liver Disease
Manco, M., Marcellini, M., Giannone, G., & Nobili, V. (2007) · American Journal of Clinical Pathology · doi:10.1309/6vj4dwgydu0xyj8q · Cited by 170
Nonalcoholic Fatty Liver Disease as a Complication of Insulin Resistance
Abdelmalek, M. F., & Diehl, A. M. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.001 · Cited by 170
Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet
Zhang, Y.-K. J., Yeager, R. L., Tanaka, Y., & Klaassen, C. D. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.03.016 · Cited by 170
Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes
Läutamaki, R., Borra, R., Iozzo, P., Komu, M. E. S., Lehtimäki, T. J., Salmi, M., Jalkanen, S., Airaksinen, J. K. E., Knuuti, J. M., Parkkola, R., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00604.2005 · Cited by 170
Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
Mokhtari, Z., Gibson, D. L., & Hekmatdoost, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013151 · Cited by 170
Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Jaruvongvanich, V., Sanguankeo, A., Riangwiwat, T., & Upala, S. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0009.8593 · Cited by 170
Functional proteomics of nonalcoholic steatohepatitis: Mitochondrial proteins as targets of S -adenosylmethionine
Santamaría, E., Avila, M. A., Latasa, M. U., Rubio, Á., Martín‐Duce, A., Lu, S. C.-L., Mato, J. M., & Corrales, F. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536625100 · Cited by 170
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
Jornayvaz, F. R., Birkenfeld, A. L., Jurczak, M. J., Kanda, S., Guigni, B. A., Jiang, D. C., Zhang, D., Lee, H., Samuel, V. T., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103451108 · Cited by 169
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
Younossi, Z. M., Otgonsuren, M., Venkatesan, C., & Mishra, A. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.005 · Cited by 169
Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease
Abe, M., Miyake, T., Kuno, A., Imai, Y., Sawai, Y., Hino, K., Hara, Y., Hige, S., Sakamoto, M., Yamada, G., et al. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-1007-2 · Cited by 169
Melatonin ameliorates nonalcoholic fatty liver induced by high‐fat diet in rats
Pan, M., Song, Y., Xu, J., & Gan, H. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00346.x · Cited by 169
The liver diseases of lipodystrophy: The long-term effect of leptin treatment
Zadeh, E. S., Lungu, A. O., Cochran, E. K., Brown, R. J., Ghany, M. G., Heller, T., Kleiner, D. E., & Görden, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.007 · Cited by 169
Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets
Li, J., Huang, J., Li, J., Chen, H., Huang, K., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.018 · Cited by 169
Nonalcoholic Fatty Liver Disease and Carotid Atherosclerosis in Children
Pacifico, L., Cantisani, V., Ricci, P., Osborn, J. F., Schiavo, E., Anania, C., Ferrara, E., Dvisic, G., & Chiesa, C. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318165b8e7 · Cited by 169
The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
Shabalala, S. C., Dludla, P. V., Mabasa, L., Kappo, A. P., Basson, A. K., Pheiffer, C., & Johnson, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110785 · Cited by 169
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
Yilmaz, Y. N. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i6.837 · Cited by 169
Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients
Diab, D. L., Yerian, L. M., Schauer, P. R., Kashyap, S. R., López, R., Hazen, S. L., & Feldstein, A. E. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.07.016 · Cited by 169
A 360-degree overview of paediatric NAFLD: Recent insights
Nobili, V., Svegliati‐Baroni, G., Alisi, A., Miele, L., Valenti, L. V. C., & Vajro, P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.003 · Cited by 168
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question
Streba, L. A. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4103 · Cited by 168
Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice
Park, H. J., DiNatale, D. A., Chung, M., Park, Y., Lee, J., Koo, S. I., O'Connor, M., Manautou, J. E., & Bruno, R. S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.03.009 · Cited by 168
Consequences of Childhood Obesity
Lee, Y. S. (2009) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v38n1p75 · Cited by 168
Controlled attenuation parameter ( CAP ) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population
Chon, Y. E., Jung, K. S., Kim, S. U., Park, J. Y., Park, Y. N., Kim, D. Y., Ahn, S. H., Chon, C. Y., Lee, H. W., Park, Y., et al. (2013) · Liver International · doi:10.1111/liv.12282 · Cited by 168
Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Coates, L. C., FitzGerald, O., Helliwell, P., & Paul, C. F. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.05.012 · Cited by 168
Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action
Scorletti, E., & Byrne, C. D. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.03.001 · Cited by 168
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis
Jung, J., Loomba, R., Imajo, K., Madamba, E. V., Gandhi, S., Bettencourt, R., Singh, S., Hernandez, C., Valasek, M. A., Behling, C. A., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322976 · Cited by 168
Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Nakahara, T., Hyogo, H., Yoneda, M., Sumida, Y., Eguchi, Y., Fujii, H., Ono, M., Kawaguchi, T., Imajo, K., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0911-1 · Cited by 167
Prevalence of Nonalcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Gambarin‐Gelwan, M., Kinkhabwala, S. V., Schiano, T. D., Bodian, C., Yeh, H., & Futterweit, W. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.010 · Cited by 167
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
Zheng, S., Hoos, L. M., Cook, J., Tetzloff, G. G., Davis, H. R., van Heek, M., & Hwa, J. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.045 · Cited by 167
Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients
Askari, F., Rashidkhani, B., & Hekmatdoost, A. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.11.005 · Cited by 167
Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach
Prieto-Hontoria, P. L., Pérez‐Matute, P., Fernández‐Galilea, M., Bustos, M., Martínez, J. A., & Moreno-Aliaga, M. J. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.11.004 · Cited by 167
Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.
de la Monte, S. M., Longato, L., Tong, M., & Wands, J. R. (2009) · PubMed · Cited by 167
Nonalcoholic steatohepatitis: Histologic features and clinical correlations with 30 blinded biopsy specimens
Brunt, E. M., Neuschwander‐Tetri, B. A., Oliver, D. A., Wehmeier, K. R., & Bacon, B. R. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.04.017 · Cited by 167
Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis
Gauthier, M., Couturier, K., Latour, J.-G., & Lavoie, J.-M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01164.2002 · Cited by 167
Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study
Wang, C.-S., Wang, S.-T., Yao, W.-J., Chang, T.-T., & Chou, P. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm061 · Cited by 166
Non-Alcoholic Fatty Liver Disease
Weiß, J., Rau, M., & Geier, A. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0447 · Cited by 166

Authors: Angulo, P.
Affiliations: Mayo Clinic (US)
Corresponding author: Angulo, Paul
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2002-04-18
Volume: 346
Issue: 16
Pages: 1221-1231
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra011775
OpenAlex: W2040109162
Cited by: 5,228
References: 90
Citations by year: 2026: 38 · 2025: 80 · 2024: 102 · 2023: 171 · 2022: 155 · 2021: 191 · 2020: 246 · 2019: 228 · 2018: 222 · 2017: 264 · 2016: 275 · 2015: 339 · 2014: 368 · 2013: 319 · 2012: 309
FWCI: 23.15
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: non-alcoholic fatty liver disease, hepatic steatosis, steatohepatitis, liver fibrosis, liver cirrhosis, obesity, type 2 diabetes, hyperlipidemia, risk factors, alcohol abuse
MeSH terms: Biopsy, Fatty Liver, Humans, Liver, Liver Function Tests, Radiography, Risk Factors, Ultrasonography, Weight Loss, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic Fatty Liver Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks